Leonteq Securities’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$948 Hold
9
– – ﹤0.01% 1184
2026
Q2
$675 Sell
9
-360
-98% -$23.1K ﹤0.01% 1201
2026
Q1
$20.8K Hold
369
– – ﹤0.01% 990
2025
Q4
$29.6K Sell
369
-1,370
-79% -$92K ﹤0.01% 1040
2025
Q3
$84.8K Sell
1,739
-1,564
-47% -$96.8K ﹤0.01% 781
2025
Q2
$246K Sell
3,303
-37
-1% -$2.45K 0.01% 520
2025
Q1
$212K Buy
3,340
+1,215
+57% +$82.6K 0.01% 532
2024
Q4
$166K Buy
+2,125
New +$171K 0.01% 584

Other funds holding HAE

Leonteq Securities's HAE Position: Q3 2026 in Review

Leonteq Securities held its Haemonetics (HAE) position steady in Q3 2026 at 9 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

Leonteq Securities first reported a position in HAE in Q4 2024 and has held it in 8 quarters since. The position peaked at $246K in Q2 2025. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Leonteq Securities held 9 shares of Haemonetics worth $948 as of Q3 2026.
  • Leonteq Securities left its Haemonetics share count unchanged in Q3 2026.
  • Haemonetics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1184 holding.
  • Leonteq Securities first reported a position in Haemonetics in Q4 2024 and has held it in 8 quarters since.
  • Leonteq Securities's Haemonetics position peaked at $246K in Q2 2025.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.